Neonatal Abstinence Syndrome amp Breastfeeding Special Populations Caitlin Vanini CPNP CNNP amp Stephanie Solpietro CPNP NEONATAL ABSTINENCE SYNDROME OBJECTIVES UNDERSTAND THE CURRENT STATUS OF MATERNAL OPIOD USE AND NEONATAL ABSTINENCE SYNDROME NAS AND ITS AFFECT ON COST AND LENG ID: 676243
Download Presentation The PPT/PDF document "Hot Topics in Newborn Care:" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Hot Topics in Newborn Care:Neonatal Abstinence Syndrome & Breastfeeding Special Populations
Caitlin Vanini C-PNP, C-NNP & Stephanie Solpietro C-PNP Slide2
NEONATAL ABSTINENCE SYNDROMESlide3
OBJECTIVES
UNDERSTAND THE CURRENT STATUS OF MATERNAL OPIOD USE AND NEONATAL ABSTINENCE SYNDROME (NAS) AND ITS’ AFFECT ON COST AND LENGTH OF STAY
DESCRIBE NAS AND ITS’ CLINICAL MANIFESTATIONS
DESCRIBE MONITORING, EVALUATION OF AND TREATMENT OF NAS
DESCRIBE THE PRIMARY CARE PROVIDERS ROLE IN FOLLOW UP FOR PATIENTS WHO HAVE EXPERIENCED NASSlide4
What is Neonatal Abstinence Syndrome
The clinical findings in the neonate associated with opioid exposure and withdrawal
Hudak, M. L., & Tan, R. C. (2012). Neonatal Drug Withdrawal.
Pediatrics,
129
(2). Slide5
INCIDENCE
Opioid Prescriptions Dispensed by Retail Pharmacies—United States, 1991–2011
Prescription Pain Medication Use on the Rise
Balancing Pain Management and Prescription Opioid Abuse. (2012). Retrieved January 11, 2016, from http://www.cdc.gov/primarycare/materials/opoidabuse/index.html Slide6
One Study with a national sample found that Antepartum maternal opiate use increased from 1.19 per 1,000 hospital births in 2000 to 5.63 in 2009
Patrick, S., Schumacher, R., Benneyworth, B., Krans, E., Mcallister, J., & Davis, M. (2013). Neonatal Abstinence Syndrome and Associated Health Care Expenditures.
Obstetric Anesthesia Digest,
33
(2), 86. Slide7
U.S. Heroin Epidemic
Heroin use more than doubled among young adults ages 18–25 in the past decade.
More than 9 in 10 people who used heroin also used at least one other drug.
45% of people who used heroin were also addicted to prescription opioid painkillers.
Today’s Heroin Epidemic. (2015). Retrieved January 11, 2016, from http://www.cdc.gov/vitalsigns/heroin/ Slide8
Today’s Heroin Epidemic. (2015). Retrieved January 11, 2016, from http://www.cdc.gov/vitalsigns/heroin/ Slide9
Commonly Used Opioids
Methadone –
Commonly used in treatment program
Buprenorphine –
Commonly used in treatment program
Morphine
Oxycodone
Hydromorphone
Hydrocodone
FentanylHeroin
Hudak, M. L., & Tan, R. C. (2012). Neonatal Drug Withdrawal. Pediatrics,
129(2). Slide10
Data Analyzed from infants with neonatal abstinence syndrome from 2004 through 2013 in 299 neonatal intensive care units (NICUs) across the United States.
The rate of NICU admissions for the neonatal abstinence syndrome increased from 7 cases per 1000 admissions to 27 cases per 1000 admissions
The total percentage of NICU days nationwide that were attributed to the neonatal abstinence syndrome increased from 0.6% to 4.0%
Tolia, V. N., Patrick, S. W., Bennett, M. M., Murthy, K., Sousa, J., Smith, P. B. (2015). Increasing Incidence of the Neonatal Abstinence Syndrome in U.S. Neonatal ICUs. New England Journal of Medicine N Engl J Med, 372(22), 2118-2126.Slide11
Increased Risk of Readmission
A study in NYS from 2006 to 2009 showed when compared with uncomplicated term infants, infants diagnosed with NAS were more than
2x
as likely to be readmitted to the hospital 30 days of birth hospitalizations.
Patrick, S. W., Burke, J. F., Biel, T. J., Auger, K. A., Goyal, N. K., & Cooper, W. O. (2015). Risk of Hospital Readmission Among Infants With Neonatal Abstinence Syndrome.
Hospital Pediatrics,
5
(10), 513-519.Slide12
Dramatic Increases in Maternal Opioid Use and Neonatal Abstinence Syndrome. (2015). Retrieved January 11, 2016, from http://www.drugabuse.gov/related-topics/trends-statistics/infographics/dramatic-increases-in-maternal-opioid-use-neonatal-abstinence-syndrome Slide13
HIGH RATES IN WESTERN NY
Newborn drug-related diagnosis rate per 10,000 newborn discharges
2007 2011-2013
New York City: 45.5 66.6
Ontario County 86.5 165.3
Monroe County (Rochester): 85.6 180.2
Erie County (Buffalo): 123.7 228.7
Onondaga County: 221 248.8
New York state: 58.4 95
REGIONS WITH THE HIGHEST RATES:
WESTERN NY REGION TOTAL 219.4
FINGER LAKES REGION TOTAL 159.4
Newborn drug-related (2014, December.). Retrieved January 11, 2016, from https://www.health.ny.gov/statistics/chac/hospital/h46.htm Slide14
MONROE COUNTY Newborn drug-related diagnosis rate per 10,000 newborn discharges
Newborn drug-related (2014, December.). Retrieved January 11, 2016, from https://www.health.ny.gov/statistics/chac/hospital/h46.htm Slide15
State Medicaid Programs Paying the Majority of the Cost
Cost is 15 to 16 times higher than healthy infants
Cost is rising –Mean hospital charges for discharges with NAS increased from $39,400 in 2000 to $53,400 in 2009
Patrick, S., Schumacher, R., Benneyworth, B., Krans, E., Mcallister, J., & Davis, M. (2013). Neonatal Abstinence Syndrome and Associated Health Care Expenditures.
Obstetric Anesthesia Digest,
33
(2), 86.
Roussos-Ross, K., Reisfield, G., Elliot, I., Dalton, S., & Gold, M. (2015). Opioid Use in Pregnant Women and the Increase in Neonatal Abstinence Syndrome. Journal of Addiction Medicine, 9(3), 222-225.Slide16
Hospital in Florida studies cost and length of stay related to NAS from 2008 -2011
NAS not requiring pharmacologic intervention
Treated with Morphine
Normal Newborns
Length of Stay
5
23
1-2
Hospital Charges
4215
43000
873-1746
Roussos-Ross, K., Reisfield, G., Elliot, I., Dalton, S., & Gold, M. (2015). Opioid Use in Pregnant Women and the Increase in Neonatal Abstinence Syndrome. Journal of Addiction Medicine, 9(3), 222-225.Slide17
Screening
Maternal History
Maternal Urine Drug Screen
Infant Drug Screen - can have false negative as it requires recent exposure to be accurate
Meconium testing - often not available at hospitals and not practical as it delays diagnosis
Bio, L. L., Siu, A., & Poon, C. Y. (2011). Update on the pharmacologic management of neonatal abstinence syndrome. J Perinatol Journal of Perinatology, 31(11), 692-701.
Hudak, M. L., & Tan, R. C. (2012). Neonatal Drug Withdrawal.
Pediatrics,
129(2). Slide18
SIGNS OF WITHDRAWAL IN NEWBORNS
Onset, severity, presentation and signs of withdrawal vary greatly among each infant
Increased Temperature
Skin Mottling
Yawning Sneezing
Nasal Stuffiness
Tachypnea
Increased Metabolic Rate with High Calorie RequirementsSlide19
SIGNS OF WITHDRAWAL IN NEWBORNS
Excessive sucking/uncoordinated suck
Poor feeding
Weight loss/Poor Gain
Reflux
Loose watery stools —> diaper rashSlide20
SIGNS OF WITHDRAWAL IN NEWBORNS
High pitched Cry/Excessive Crying
Irritability
Excoriation
Poor Sleep
Hypertonia
Tremors disturbed or undisturbed
SeizuresSlide21
Onset of Withdrawal
Methadone
Heroin
Buprenorphine
24-72 hours
Within 24 hours from birth
~ 40 hours
Infants are typically monitored for a minimum of 72-96 hours for signs of Withdrawal
Withdrawal onset can be delayed for up to 5-7 days
Hudak, M. L., & Tan, R. C. (2012). Neonatal Drug Withdrawal.
Pediatrics,
129
(2). Slide22
FINNEGAN SCORING SYSTEM
Most widely used tool in the US
Scores are used to help quantify the severity of the withdrawal and they are used as a guide to start, wean and discontinue treatment
A normal newborn can have scores as high as 8
At SMH treatment is typically initiated with consistent scores > 8
Training of staff completing scoring very important
Examination of infant just as important as evaluation of scores as scores can be somewhat subjective
Scores are a reflection of a period of time and not one moment in time
Trending scores over time is important in determining management Slide23
Hudak, M. L., & Tan, R. C. (2012). Neonatal Drug Withdrawal.
Pediatrics,
129
(2). Slide24
Goal of Therapy
To alleviate the symptoms of NAS and to prevent complications including fevers, seizures, discomfort, weight loss etc.
Attain sufficient sleep and nutrition
Establish pattern of weight gain
The goal is NOT to eliminate every single symptom
Hudak, M. L., & Tan, R. C. (2012). Neonatal Drug Withdrawal.
Pediatrics,
129
(2). Slide25
NON-PHARMACOLOGIC MANAGEMENT
Decrease Environmental Stimuli
Dim lighting
Quiet environment
Swaddling
Decreased Handling
Pacifier
Firm prolonged touch vs frequent stroking etc.Slide26
Multidisciplinary Approach
Medical Providers
Nurses
Parents
Social workSlide27
CAN THESE INFANTS BREASTFEED?
YES! As long as the mother is in a supervised treatment program
There may be other medications or diseases that may be contraindicated, however most of the infant’s treated at SMH can breastfeed if desired!
If mother is unable to breastfeed or desires to use formula then often Gentlease or it’s equivalent is used given the GI symptoms that occur with NAS
Mother’s need to be reassured that despite being on prescribed opioids there is still overall benefit!
Methadone and Buprenorphine transfer to breast milk is very small
BF has been associated with less severe NAS with later onset of withdrawal and less need for pharmacologic treatment
If mother hepatitis C positive – this is not a contraindication unless mother has bleeding or cracked nipples
Hudak, M. L., & Tan, R. C. (2012). Neonatal Drug Withdrawal.
Pediatrics,
129
(2). Slide28
PHARMACOLOGIC MANAGEMENT - MORPHINE
Short half life allows for weaning, shorter half life than Methadone
Dosed every 4 hours
Infant needs to be monitored during initial therapy for signs of respiratory depression Due to decreased responsiveness to carbon dioxide tension
Opioids decrease pain perception and cause euphoria and sedation.
They also decrease GI motility resulting in constipation and anorexia.
At SMH - Once infant “captured” on dose with stable scores for ~ 48 hours then the dose is weaned 10-20% every 1-3 days until discontinued
At SMH - Once discontinued infant is monitored in the hospital for an additional 24-48 hours to ensure there is no rebound withdrawal
Bio, L. L., Siu, A., & Poon, C. Y. (2011). Update on the pharmacologic management of neonatal abstinence syndrome. J Perinatol Journal of Perinatology, 31(11), 692-701.
Hudak, M. L., & Tan, R. C. (2012). Neonatal Drug Withdrawal. Pediatrics, 129(2). Slide29
PHARMACOLOGIC MANAGEMENT – PHENOBARBITAL 2nd line agent
Most commonly used when there is history of poly -substance use
May be used with severe NAS or when morphine is very difficult to wean
suppresses hyperactivity, decreases CNS activity, helps to control insomnia and irritability . Does not have any affect on opioid specific withdrawal symptoms such as diarrhea and poor feeding
Long half life - drug may not need to be given every day
Infant may be discharged on Phenobarbital with pre-planned taper and close follow up by PCP
Bio, L. L., Siu, A., & Poon, C. Y. (2011). Update on the pharmacologic management of neonatal abstinence syndrome. J Perinatol Journal of Perinatology, 31(11), 692-701.
Hudak, M. L., & Tan, R. C. (2012). Neonatal Drug Withdrawal. Pediatrics, 129(2). Slide30
PHARMACOLOGIC MANAGEMENT - Other Therapies That Have Been Used
Tincture of opium
Methadone
Clonidine - for poly-substance
diazepam - for poly-substance
Buprenorphine has recently been under investigation as an option to consider in the management of NAS
Bio, L. L., Siu, A., & Poon, C. Y. (2011). Update on the pharmacologic management of neonatal abstinence syndrome. J Perinatol Journal of Perinatology, 31(11), 692-701.
Hudak, M. L., & Tan, R. C. (2012). Neonatal Drug Withdrawal. Pediatrics, 129(2). Slide31
Protocol Used At SMH
Approaches at each hospital may be slightly different. It is important to have a standardized approach to assessment with a scoring system and a protocol for management.
NAS Flowsheet. (2014, July.) Retrieved January 11, 2016 from https://connect.urmc.rochester.edu/ CSCOE /portal.htmSlide32
Decreased Risk Of Withdrawal After Opioid Exposure In Preterm Infants
Immature central nervous system
Decreased fat deposition of drug
Decreased length of drug exposure in utero
Inability to express motor dysfunction as compared to term infants i.e. tremors
Hudak, M. L., & Tan, R. C. (2012). Neonatal Drug Withdrawal.
Pediatrics,
129
(2).
Dysart, K., Hsieh, H., Kaltenbach, K., & Greenspan, J. S. (2007). Sequela of preterm versus term infants born to mothers on a methadone maintenance program: Differential course of neonatal abstinence syndrome.
Journal of Perinatal Medicine, 35(4). Slide33
FOLLOW UP
A visiting nurse often sent to infant’s home in the first few days after discharge to
assess weight, feeding and vital signs.
Close follow up in the first few days after discharge is indicated to evaluate for continued withdrawal.
At SMH all infants are seen in the Kirch Pediatric Developmental Clinic at 3 months of age
CPS involvement often ongoing after discharge. Note: If mother in a treatment program at time of delivery then CPS will not be notified
Mother may be given referral for outpatient social workerSlide34
THE PRIMARY CARE PROVIDERS ROLE
Monitor weight gain closely given high metabolic demands
Determine if infant requires increased caloric density or if infant has stable or excessive weight gain they can be transitioned off higher calorie formula or BM
Advocate for child if parental substance use is suspected to be continuing by reporting to CPS
Work with in-patient clinician on weaning phenobarbital if infant is to go home on medication
Understand the clinical manifestations of NAS and determine if infant experiencing clinically significant withdrawal that would require initial admission or readmission
Understand that withdrawal can occur after hospital discharge and still may require hospitalization
Many times mothers also have a diagnosis of hepatitis C at time of delivery. Be sure to screen at risk infant’s for disease according to Red Book guidelines
Continue to follow infant’s development and refer for evaluation as indicatedSlide35
OUTCOMES
More research needs to be done! Very limited data on long term outcomes of in utero exposed infants.
Dysfunctional caregivers and other environmental variables make interpretation of outcomes difficult
Hudak, M. L., & Tan, R. C. (2012). Neonatal Drug Withdrawal.
Pediatrics,
129
(2). Slide36
The Breastfeeding Newborn
:
Special PopulationsSlide37
Objectives
State AAP recommendations for breastfeeding newborns
Identify Healthy People 2020 goals for breastfeeding
Identify important interview points for the breastfeeding mother
Identify special considerations necessary when caring for late preterm infant
Create a feeding plan to optimize growth in the late preterm infant, infant with significant weight loss, and infant with tongue tie
Recognize newborn with tongue tie and make necessary referral and feeding plan to optimize growth
Identify resources for mothers to obtain breast pumps and lactation supportSlide38
Breast Feeding Recommendations
AAP recommends exclusive breast feeding for the first 6 months of life, then continued breast feeding with the introduction of complimentary foods
According to the CDC 2014 Breast Feeding Report Card:
“In 2011, 79% of newborn infants started to breastfeed. Yet breastfeeding did not continue for as long as recommended. Of infants born in 2011, 49% were breastfeeding at 6 months and 27% at 12 months.”Slide39
What makes breast milk optimal nutrition?
Breast milk is a “complex and dynamic fluid that supports ideal infant growth and immune function development.
The composition of human milk changes over time, and contains live cells along with macronutrients and micronutrients and bioactive factors.”
(Denne 2015)
Colostrum is the first milk, it begins to produced during the second trimester of pregnancy and is available in relatively low volumes during the first days following delivery. I
t is rich in secretory IgA, lactoferrin, leukocytes, and epidermal growth factor
Breast milk transitions to mature milk during over the next 2-4 weeks. I
t is rich in lactose, fat, immunoglobulins and total proteins
(Denne 2015)Slide40
Important questions for breast feeding mothers
Complete history:
Medical and obstetric history
Daily medications and supplements
Did she experience breast changes during the first trimester of pregnancy
Maternal breast feeding goals
How long does mother want to breast feed for?
Does she wish to feed at the breast or pump breast milk for bottle feeding
What is her previous breast feeding experience and does she have support at home
Maternal access to breast pumps
thanks to the Affordable Care Act, most new mothers will be able to attain an electric breast pump through insurance, these are generally available through a durable medical equipment supplyMothers with WIC may be able to obtain a breast pump through the WIC peer counselorSlide41
Special populations
Late Preterm or Small Infants
Tongue Tie
Significant Weight LossSlide42
Breastfeedingthe late preterm infant
Infants born between 34 0/7 weeks and 36 6/7 weeks gestation are:
75% of preterm births and they:
“lag behind in terms of their cardiorespiratory, metabolic, immunologic, neurologic, and motor development”
“4 times more likely than term infants to be diagnosed with jaundice, respiratory distress, poor feeding, temperature instability, or hypoglycemia during the birth hospitalization”
Breast fed late preterm infants are more likely to be readmitted to hospital than formula fed counterparts due to failure to thrive, jaundice and dehydration
(Radtke 2011)Slide43
Wight, Pediatric Annals 2003; 32:5
Less stamina
Less coordinated S/S/B
Less effective suckling
Less alert, awake periods
Insufficient milk transfer
Hypoglycemia
Jaundice
Poor weight gain
Readmission
Supplementation
Separation from mother
Insufficient milk supply
Insufficient breast stimulation
Incomplete emptyingSlide44
Breastfeedingthe late preterm infant
American Academy of Breastfeeding Medicine Guideline
Inpatient:
Communicate feeding plan with late preterm order set and modify daily as needed given infant status (weight loss, physiologic stability)
Encourage rooming in and ad lib breast feeding (at least every 2-3hours)
Educate parents about waking techniques, ways to facilitate effective latch and hold
Ensure daily formal breast feeding assessment
If supplementation is required: 5-10ml/feed on day 1 and 10-30ml/feed day 2 and on. Mother should pump if supplementation is required
(Academy of Breastfeeding Medicine, 2011)Slide45
Breastfeedingthe late preterm infant
Role of the Primary Care Provider
Before hospital discharge:
Ensure effective at breast feeding with daily evaluation of feeding quality by hospital lactation services
Closely monitor weight and bilirubin
Create home breast feeding plan based on weight/weight loss and bilirubin, as well as maternal factors and desires
In PcP office
First visit 24-48hrs following hospital discharge
Continued close monitoring of weight, bilirubin and hydration
Identification of lactation support (private Lactation support company, La Leche League, WIC)
Modification of home breast feeding plan
(Academy of Breastfeeding Medicine, 2011)Slide46
Breastfeeding& tongue tie
Congenital condition causing a short, thick lingual frenulum
Effects 1.7-4.7% of newborns, causes feeding difficulties in 44% of these infants
There are potential for both short and long term sequelae of anykyloglossia, including speech difficulties, orthodontic and mandibular abnormalities and psychological problems
(Academy of Breastfeeding Medicine)Slide47
Breast feeding& tongue tie
Normal Newborn Tongue
Samples of Tongue Tie
Significant tongue tie prevents the normal tongue extension, lift and peristaltic movements during breast feeding
This results in not only trauma to the nipple due to poor latch, but can also lead to ineffective milk transfer by the baby
Leading to poor weight gain or significant weight loss in severe cases, but also poor stimulation for the mother to establish her breast milk supply
(Academy of Breastfeeding Medicine)Slide48
Breastfeeding& tongue tie
What to do??
Frenotomy is the procedure during which the tongue is released by clipping the restrictive lingual frenulum
Though some evidence reports decreased maternal nipple pain and improvements in the infants ability to latch and transfer milk – there are very few randomized controlled trials that report this procedure to be effective treatment although there is a tendency toward performing this procedure to protect breastfeeding.
If concern for tongue tie exists and is thought to be affecting feeding and weight gain, referral to ENT can be made or tongue can be clipped AND a feeding plan can be created to optimize milk transfer and weight gain, this will generally include supplementation and maternal pumping
(Academy of Breastfeeding Medicine)Slide49
Breast feeding& significant weight loss
What defines significant weight loss in newborn
In late preterm infant, weight loss of > 3% in first 24hrs or >7% by day 3 of life
Factors to consider:
Gestational age at birth as well as birth weight
Immediate postpartum course – has infant been rooming in and exclusively breast fed? Was first feeding delayed for any reason?
Maternal breast feeding history as well as past medical history that could affect breastfeeding (breast surgery, polycystic ovary syndrome, etc.)
Maternal medications (many medications can delay or hinder breastmilk production)
Experienced mother vs first time breast feeding mother
Delivery modality- vaginal vs c-sectionSlide50
Breast feeding& significant weight loss
What to do??
Significant weight loss during the newborn period can easily be remedied by providing the infant feeding via supplementary or complementary feeds, but what is the difference…
Supplementary feedings:
Feedings provided in place of breastfeeding.
Complementary feedings:
Feedings provided in addition to breastfeeding when breastmilk alone is no longer sufficient.
What to supplement with??
Best to supplement/complement at breast feedings with either expressed breast milk, however in many cases formula is required to bridge the volume gapSlide51
Breast feeding& significant weight loss
Appropriate weight gain of a normal healthy newborn is 28-34g/day poor weight gain is defined as <20g/day
How to manage significant weight loss…
Establish clear feeding plan, generally this means giving the mother a period of time during the day (4, 6, 8 or 12 hours) during which the infant may exclusively breast feed
during the remaining hours of the day the infant may breast feed but these feedings must be supplemented with formula or expressed breast milk
Identify available lactation support
Mothers are encouraged to pump if the infant is receiving supplemented feeds or has significant weight loss to stimulate an increased supply
Follow up for this group of infants should be done frequently, at least weekly until appropriate weight gain is established. Once infant is gaining weight appropriately the feeding plan can be altered to include more hours of exclusive at breast feedingSlide52
Future breastfeeding objectivesHealthy People 2020Slide53
References
Balancing Pain Management and Prescription Opioid Abuse. (2012). Retrieved January 11, 2016, from http://www.cdc.gov/primarycare/materials/opoidabuse/index.html
Bio, L. L., Siu, A., & Poon, C. Y. (2011). Update on the pharmacologic management of neonatal abstinence syndrome. J Perinatol Journal of Perinatology, 31(11), 692-701.
Denne, S.C. (2015) Neonatal Nutrition. Pediatr Clin N Am 62 (2015) 427–438. doi.10.1016j.pcl.2014.11.006
Dramatic Increases in Maternal Opioid Use and Neonatal Abstinence Syndrome. (2015). Retrieved January 11, 2016, from http://www.drugabuse.gov/related-topics/trends-statistics/infographics/dramatic-increases-in-maternal-opioid-use-neonatal-abstinence-syndrome
Dysart, K., Hsieh, H., Kaltenbach, K., & Greenspan, J. S. (2007). Sequela of preterm versus term infants born to mothers on a methadone maintenance program: Differential course of neonatal abstinence syndrome.
Journal of Perinatal Medicine,
35
(4).
Healthy People 2020 Objectives. http://www.cdc.gov/breastfeeding/policy/hp2010.htm Hudak, M. L., & Tan, R. C. (2012). Neonatal Drug Withdrawal.
Pediatrics, 129(2).
NAS Flowsheet. (2014, July.) Retrieved January 11, 2016 from https://connect.urmc.rochester.edu/ CSCOE /portal.htm
Newborn drug-related (2014, December.). Retrieved January 11, 2016, from https://www.health.ny.gov/statistics/chac/hospital/h46.htm
Patrick, S., Schumacher, R., Benneyworth, B., Krans, E., Mcallister, J., & Davis, M. (2013). Neonatal Abstinence Syndrome and Associated Health Care Expenditures.
Obstetric Anesthesia Digest,
33
(2), 86.
Radtke, J.V. (2011). The Paradox of Breastfeeding – Associated Morbidity Among Late Preterm Infants. Journal of Gynocyologic and Neonatal Nursing, 40, 9-24.
Roussos-Ross, K., Reisfield, G., Elliot, I., Dalton, S., & Gold, M. (2015). Opioid Use in Pregnant Women and the Increase in Neonatal Abstinence Syndrome. Journal of Addiction Medicine, 9(3), 222-225.
The Academy of Breastfeeding Medicine. ABM Clinical Protocol #11: Guidelines for the evaluation and management of neonatal ankyloglossia and its complications in the breastfeeding dyad. Breastfeeding Medicine
The Academy of Breastfeeding Medicine (2009). ABM Clinical Protocol #3. Hospital Guidelines for the Use of Supplementary Feedings in the Healthy Term Breastfed Neonate, Revised 2009. Breastfeeding Medicine, 4 (3) 175-182
The Academy of Breastfeeding Medicine (2011). ABM Clinical Protocol #10: Breastfeeding the Late Preterm Infant (34 0/7 to 36 6/7 Weeks Gestation). Breastfeeding Medicine, 6 (3) 151-156
Today’s Heroin Epidemic. (2015). Retrieved January 11, 2016, from http://www.cdc.gov/vitalsigns/heroin/
Tolia, V. N., Patrick, S. W., Bennett, M. M., Murthy, K., Sousa, J., Smith, P. B. (2015). Increasing Incidence of the Neonatal Abstinence Syndrome in U.S. Neonatal ICUs. New England Journal of Medicine N Engl J Med, 372(22), 2118-2126.
Wight, NE (2003). Breastfeeding the borderline (near-term) preterm infant. Pediatric Annals, 32 (5): 329-336